Results 271 to 280 of about 357,544 (339)

Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis. [PDF]

Front Immunol
Zhou J, Ye W, Ranarisoa SN, Tian L.
europepmc   +1 more source

<i>BRCA2</i> Reversion Mutation after Neoadjuvant Dose-Dense EC and Dose-Dense Paclitaxel in Triple-Negative Breast Cancer: A Case Report and Literature Review. [PDF]

Surg Case Rep
Hikino H, Otani A, Makino Y.
europepmc   +1 more source

Endoscope‐Assisted Nipple‐Sparing Mastectomy With Immediate Implant Reconstruction: A Retrospective Study

World Journal of Surgery, EarlyView.
Breast cancer surgery increasingly favors nipple‐sparing and endoscopic techniques to optimize oncological safety, cosmetic outcomes, and patient satisfaction. We aimed to evaluate and compare the clinical efficacy and postoperative safety profiles of endoscope‐assisted and conventional open approaches for nipple‐sparing mastectomy with immediate ...
Yuan Shao, Youcheng Zhang, Huafeng Kang, Qing Zhou, Ziliang Zhang, Guiru Yan, Binghua Kan   +6 more
wiley   +1 more source

Rare manifestation of paclitaxel-induced cardiotoxicity: A case of restrictive cardiomyopathy in an elderly breast cancer patient.

Indian J Pharmacol
Masum K, Srinivas S, Ramaiah B.
europepmc   +1 more source

Pacific Blue Derivatives of Paclitaxel as Fluorescent Probes of OATP1B-Type Transporters. [PDF]

Clin Transl Sci
Nepal MR, Xu Y, Jin Y, Hu P, Hu X, Rane DS, Andres AE, Ahmed EA, Steiger B, Sparreboom A, Peterson BR, Hu S.   +11 more
europepmc   +1 more source

Can Wapiti (Cervus elaphus) Browsing Stimulate the Chemical Defense of Taxus cuspidata—A Case of Northeast China Tiger and Leopard National Park

Integrative Zoology, EarlyView.
We study that browsing by wapiti reduces the growth of saplings, and it develop chemical defenses to prevent themselves browsed again. These results reduce our concern about wapiti browse T. cuspidate saplings, and provide basic data for the study of the interaction between them, and also provide theoretical basis for the population restoration and ...
Jianan Feng, Hairong Du, Xianzhe Wang, Minghai Zhang   +3 more
wiley   +1 more source

Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors. [PDF]

Front Immunol
Su Z, Zhang X, Xu J, Shen Y.
europepmc   +1 more source

Utilization of a UPLC-MS/MS Approach to Elucidate the Role of ABCB1-Mediated Paclitaxel Resistance in Non-Small Cell Lung Cancer Cells. [PDF]

Oncol Res
Hu S, Wang W, Hu Q, Zheng R, Huang Q, Shi H, Ding X, Wang W, Zhu Z.   +8 more
europepmc   +1 more source

Outcomes for Patients With Micro‐Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This retrospective study of patients with small, node‐negative HER2+ breast cancer found favorable 5‐year invasive disease‐free survival rates—93% for pT1mic/a disease and 100% for pT1b disease. Trastuzumab was administered to 66% of patients and was associated with larger tumor size and higher histologic grade.
Yuanyuan Xue, Katrina Moore, Tricia Saurine, David Chan, Lina Pugliano, Connie Diakos   +5 more
wiley   +1 more source